Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and Older
Clinical trial NCT04622592 · COMPLETED
Trial details
- NCT number
- NCT04622592
- Sponsor
- Medicago
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-02
- Primary completion
- 2022-04-26
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.